Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Epkinly

(ep-KIN-lee)
A drug used to treat adults with certain types of diffuse large B-cell lymphoma, high-grade B-cell lymphoma, or follicular lymphoma that came back or did not get better after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. Epkinly binds to a protein called CD3, which is found on T cells (a type of white blood cell). It also binds to a protein called CD20, which is found on B cells (another type of white blood cell) and some lymphoma cells. This may help the immune system kill cancer cells. Epkinly is a type of bispecific T-cell engager. Also called epcoritamab.
More Information
Search NCI's Dictionary of Cancer Terms